158 related articles for article (PubMed ID: 21431540)
1. Cell surface engineering of mesenchymal stem cells.
Sarkar D; Zhao W; Gupta A; Loh WL; Karnik R; Karp JM
Methods Mol Biol; 2011; 698():505-23. PubMed ID: 21431540
[TBL] [Abstract][Full Text] [Related]
2. Chemical engineering of mesenchymal stem cells to induce a cell rolling response.
Sarkar D; Vemula PK; Teo GS; Spelke D; Karnik R; Wee le Y; Karp JM
Bioconjug Chem; 2008 Nov; 19(11):2105-9. PubMed ID: 18973352
[TBL] [Abstract][Full Text] [Related]
3. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
Eniola AO; Hammer DA
Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
[TBL] [Abstract][Full Text] [Related]
4. Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting.
Sarkar D; Vemula PK; Zhao W; Gupta A; Karnik R; Karp JM
Biomaterials; 2010 Jul; 31(19):5266-74. PubMed ID: 20381141
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.
Sackstein R; Merzaban JS; Cain DW; Dagia NM; Spencer JA; Lin CP; Wohlgemuth R
Nat Med; 2008 Feb; 14(2):181-7. PubMed ID: 18193058
[TBL] [Abstract][Full Text] [Related]
6. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.
Frith JE; Thomson B; Genever PG
Tissue Eng Part C Methods; 2010 Aug; 16(4):735-49. PubMed ID: 19811095
[TBL] [Abstract][Full Text] [Related]
7. Polycaprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo.
Shao Z; Zhang X; Pi Y; Wang X; Jia Z; Zhu J; Dai L; Chen W; Yin L; Chen H; Zhou C; Ao Y
Biomaterials; 2012 Apr; 33(12):3375-87. PubMed ID: 22322196
[TBL] [Abstract][Full Text] [Related]
8. P-selectin glycoprotein ligand-1 mediates rolling of mouse bone marrow-derived mast cells on P-selectin but not efficiently on E-selectin.
Steegmaier M; Blanks JE; Borges E; Vestweber D
Eur J Immunol; 1997 Jun; 27(6):1339-45. PubMed ID: 9209482
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix.
Liu G; Li Y; Sun J; Zhou H; Zhang W; Cui L; Cao Y
Tissue Eng Part A; 2010 Mar; 16(3):971-82. PubMed ID: 19839720
[TBL] [Abstract][Full Text] [Related]
11. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
[TBL] [Abstract][Full Text] [Related]
12. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
13. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
Boland GM; Perkins G; Hall DJ; Tuan RS
J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.
Song H; Chang W; Lim S; Seo HS; Shim CY; Park S; Yoo KJ; Kim BS; Min BH; Lee H; Jang Y; Chung N; Hwang KC
Stem Cells; 2007 Jun; 25(6):1431-8. PubMed ID: 17347495
[TBL] [Abstract][Full Text] [Related]
15. L- and P-selectins collaborate to support leukocyte rolling in vivo when high-affinity P-selectin-P-selectin glycoprotein ligand-1 interaction is inhibited.
Ridger VC; Hellewell PG; Norman KE
Am J Pathol; 2005 Mar; 166(3):945-52. PubMed ID: 15743805
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
17. Engineered polyelectrolyte multilayer substrates for adhesion, proliferation, and differentiation of human mesenchymal stem cells.
Semenov OV; Malek A; Bittermann AG; Vörös J; Zisch AH
Tissue Eng Part A; 2009 Oct; 15(10):2977-90. PubMed ID: 19320572
[TBL] [Abstract][Full Text] [Related]
18. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
Bhakta S; Hong P; Koc O
Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.
Sotiropoulou PA; Perez SA; Salagianni M; Baxevanis CN; Papamichail M
Stem Cells; 2006 Feb; 24(2):462-71. PubMed ID: 16109759
[TBL] [Abstract][Full Text] [Related]
20. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro.
Lim YC; Snapp K; Kansas GS; Camphausen R; Ding H; Luscinskas FW
J Immunol; 1998 Sep; 161(5):2501-8. PubMed ID: 9725249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
